Investor Relations

See Stock Info

Our Mission

To achieve and deliver breakthroughs in therapies for primary and metastatic cancers through the use of drug management and delivery systems that improve clinical outcomes for patients while reducing drug-related side effects.

Core Values

Collaboration, challenge each other, stretch skills, cross-funtional trust and reliance, listening, mutual respect, fun, team goals supersede individual goals
Making a better mouse trap, revolutionizing systems, shifting the paradigm
Operating within a given set of parameters; systems in place to ensure compliance
Being #1; leading with passion and focus; aiming to win
Accountability, meeting commitments, ability to say "no," courage and creativity, laser-focused
Listening to the customer; being responsive, safety, minimizing harm, ease of use; meeting the needs of patients, physicians, investors

Press Releases

View all press releases

Corporate Presentation

Our corporate presentation offers a comprehensive overview of our innovative treatments, strategic vision, and financial performance. Discover how we are pioneering advanced oncology solutions and driving growth for a brighter future.

Events

Upcoming Events

Past Events

View all presentations & events

Corporate Governance

Leadership

Our leadership team is dedicated to driving innovation and excellence in interventional oncology.

Learn more

Governance Docs

Access our comprehensive governance documents that outline our commitment to ethical and transparent business practices.

Learn more

Committee Composition

Explore the diverse expertise and roles within our committee composition that ensure robust corporate governance.

Learn more
Disclaimer

You are about to review presentations, reports, filings and/or other materials regarding Delcath Systems, Inc. (NASDAQ: DCTH) that contain time-sensitive information. The information contained therein is only current as of the date thereof. Delcath expressly disclaims any obligation to review, update or correct these materials after the date thereof. Delcath may update, amend, supplement or otherwise alter the information contained in any such materials by subsequent presentations, reports, filings, or other means without notice. Certain statements made on this Web site or in materials accessed in or through this section of our Web site are “forward–looking statements,” which are subject to risks and uncertainties, and Delcath’s actual results may differ (possibly materially) from those indicated in such statements. Data Provided by Thomson Reuters.